Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 SSO Annual Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Speaker
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
G
Gabriel, Emmanuel
Mayo Clinic Florida
P41: A Multi-Institution Observational Analysis of the Theory of the Immunization Effect in Patients with Multiple Primary Melanomas
Location:SSO HUB: Melanoma & Sarcoma Zone
Emmanuel Gabriel
Gabrielova, Lucie
Department of Surgery, Masaryk Memorial Cancer Institute, Brno, Zluty kopec, Czech Republic
77: Current Patterns of Care and Outcomes for Dermatofibrosarcoma Protuberans: An International Multi-institutional Collaborative
Location:Ballroom A
Lucie Gabrielova
Gallagher, Kristalyn
University of North Carolina at Chapel Hill
4: Germline Genetic Mutations in a Prospective Multi-Center Cohort of 241 Phyllodes Tumors; Time to Expand Testing Criteria
Location:Veterans Memorial Auditorium
Kristalyn Gallagher
Gamboa, Adriana
Emory University
26: Neoadjuvant Chemoradiation Does Not Improve Outcomes for Patients Undergoing Resection for Upper Rectal Cancer: A US Rectal Cancer Consortium Analysis
Location:Ballroom C
Adriana Gamboa
Gangi, Alexandra
Cedars Sinai Medical Center
32: Impact of Primary Tumor Resection on Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors
Location:Ballroom A
Alexandra Gangi
Shark Tank: What’s the Next Big Clinical Trial in Pancreas Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Alexandra Gangi
Ganguly, Anutosh
University of Michigan Medical School
P46: Histotripsy ablation abrogates tumor hypoxia and induces immunogenic cancer cell death
Location:SSO HUB: Melanoma & Sarcoma Zone
Anutosh Ganguly
Gao, Jinming
Allegheny Health Network
65: Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH Sensitive Imaging Agent: Topline Results from a Phase 2 Study
Location:Veterans Memorial Auditorium
Jinming Gao
Gao, Mei
Department of Surgery, The University of Kentucky College of Medicine
P40: Exosomal isolation of immune checkpoints from pancreatic ductal adenocarcinoma patient-derived organoids
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Mei Gao
Gao, Zachary
Baylor College of Medicine
45: Differential Immune Signatures are Associated with Racial Disparities in Pancreatic Cancer
Location:Ballroom A
Zachary Gao
Garcia-Aguilar, Julio
Memorial Sloan Kettering Cancer Center
21: Organ Preservation, Compliance and Toxicity in Rectal Cancer Patients Treated with Total Neoadjuvant Therapy: A Post Hoc Analysis of the of the OPRA Phase II Trial
Location:Ballroom C
Julio Garcia-Aguilar
P20: Microsatellite Instability (MSI): The Transition from Favorable to Unfavorable Outcomes with Lymph Node Metastases
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Julio Garcia-Aguilar
Garcia, Paula
Memorial Sloan Kettering Cancer Center
P11: Satisfaction and well-being after contralateral prophylactic mastectomy among BRCA mutation carriers and non-carriers: a longitudinal analysis of BREAST-Q domains
Location:SSO HUB: Breast & Endocrine Zone
Paula Garcia
Garduno, Nicole
University of Colorado School of Medicine, Department of Surgery
P77: Prospective Evaluation of a Universally Applied Laparoscopic Gastric Ischemic Preconditioning Protocol Prior to Esophagectomy with Comparison to Historical Controls
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Nicole Garduno
Garmendia-Cedillos, Marcial
NIBIB
P51: Hyperthermic intraperitoneal chemotherapy restores physiologic tumor stiffness & stimulates lymphocyte proliferation & recruitment
Location:SSO HUB: Rare/Metastatic Cancers Zone
Marcial Garmendia-Cedillos
Garrido, Vanessa
University of Miami, Miller School of Medicine, Department of Surgery
P32: p38 MAPK inhibition reprograms the inflammatory stroma to overcome the immunosuppressive tumor microenvironment in pancreatic cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Vanessa Garrido
Gasparoli, Camilla
Mayo Clinic
P61: Outcomes After Resection of Locally Recurrent Retroperitoneal Sarcoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Camilla Gasparoli
Gastman, Brian
Cleveland Clinic Foundation, Cleveland, OH, USA
54: Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Tumor Location in the Phase 3 KEYNOTE-716 Study
Location:Veterans Memorial Auditorium
Brian Gastman
63: Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)
Location:Veterans Memorial Auditorium
Brian Gastman
Gawad, Wael
National Cancer Institute, Cairo University- Ministry of National Guard Health Affairs-MNGHA-Eastern Province -KSA
GPPO3: The Impact of Enhanced Recovery Protocol (ERAS) In patients with Peritoneal Surface Malignancies (PSM) Managed with Cytoreductive Surgery (CRS) & Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Model for Multi-Institutional International Collaboration
Location:Ballroom C
Wael Gawad
Genetics Center, Regeneron
Regeneron Genetics Center
P25: What are the clinical implications of SDHA pathogenic variants?
Location:SSO HUB: Breast & Endocrine Zone
Regeneron Genetics Center
George, Ben
Medical College of Wisconsin
48: Machine Learning Derived Electronic Tumor Marker Mimics Prognostic Properties of CA19-9
Location:Ballroom A
Ben George
Georger, Mary
University of Rochester Medical Center
38: Semaphorin 4D is Expressed by Activated Lymphocytes in Pancreatic Adenocarcinoma, and Monoclonal Blockade Sensitizes Murine Tumors to Immune Checkpoint Therapy
Location:Ballroom B
Mary Georger
44: Pten deletion-induced murine model of cholangiocarcinoma: a pathologic and immune analysis
Location:Ballroom B
Mary Georger
46: Pan-Lysyl Oxidase Inhibition Disrupts Macrophage Invasion and Renders Tumor-Associated Macrophages Susceptible to Cytotoxic Chemotherapy in Cholangiocarcinoma
Location:Ballroom A
Mary Georger
P34: Determining Safety and Tolerability of SX-682 in Combination with Anti-PD1 as Maintenance Therapy for Unresectable Pancreatic Adenocarcinoma, A Phase I Study
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Mary Georger
Gergen, Anna
University of Colorado School of Medicine, Department of Surgery
P77: Prospective Evaluation of a Universally Applied Laparoscopic Gastric Ischemic Preconditioning Protocol Prior to Esophagectomy with Comparison to Historical Controls
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Anna Gergen
Gershenwald, Jeffrey
The University of Texas MD Anderson Cancer Center
54: Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Tumor Location in the Phase 3 KEYNOTE-716 Study
Location:Veterans Memorial Auditorium
Jeffrey Gershenwald
Gersz, Elaine
Vaccinex, Inc.
38: Semaphorin 4D is Expressed by Activated Lymphocytes in Pancreatic Adenocarcinoma, and Monoclonal Blockade Sensitizes Murine Tumors to Immune Checkpoint Therapy
Location:Ballroom B
Elaine Gersz
Ghaffar, Aqsa
University of Rochester Medical Center
85: Impact of Incident Hospital-Acquired Geriatric Syndromes on Short-term Outcomes following Gastrointestinal Cancer Resection
Location:Ballroom B
Aqsa Ghaffar
Gholami, Sepideh
Northwell Health
Beyond Wedges: Extreme Parenchyma Preservation, Debulking, Combined Ablation
Location:Ballroom B
Sepideh Gholami
P37: Characterization of Natural Killer and Cytotoxic T Cell Immune Infiltrates in Pancreatic Ductal Adenocarcinoma
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Sepideh Gholami
Questions and Discussion
Location:Ballroom B
Sepideh Gholami
Ghosh, Pradipta
Department of Cellular and Molecular Medicine, University of California San Diego
P83: Primary and Metastatic Gastric Cancers in Patient-derived Orthotopic Xenografts Brightly Labeled by Fluorescent anti-CEA Antibody
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Pradipta Ghosh
Giannakeas, Vasily
Women's College Research Institute
6: Population-based survival outcomes of pure vs mixed invasive Lobular Breast Carcinoma in Ontario, Canada
Location:Veterans Memorial Auditorium
Vasily Giannakeas
Ginzberg, Sara
Hospital of the University of Pennsylvania
P23: Resection of the Primary Tumor Improves Survival in Metastatic Adrenocortical Carcinoma
Location:SSO HUB: Breast & Endocrine Zone
Sara Ginzberg
Gironda, Daniel
Wake Forest University
66: Utilizing Organoids to Study Perfusate Selection in Appendiceal Cancer Patients Undergoing Repeat HIPEC
Location:Ballroom B
Daniel Gironda
Giuliano, Armando
Cedars-Sinai Medical Center
1: Impact of Breast Conservation Therapy on Local Recurrence in Patients with Multiple Ipsilateral Breast Cancer – Results from ACOSOG Z11102 (Alliance)
Location:Veterans Memorial Auditorium
Armando Giuliano
15: A Prospective Study of Sentinel Node Biopsy Omission in Women Age ≥ 65 with Early Invasive ER+ Breast Cancer Undergoing Breast Conserving Surgery
Location:Veterans Memorial Auditorium
Armando Giuliano
18: Clinical Impact of Semi-Annual Mammography in Patients Undergoing Breast Conserving Surgery Following Neoadjuvant Therapy
Location:Veterans Memorial Auditorium
Armando Giuliano
Gjorup, Caroline
Melanoma Institute Australia; The University of Sydney
56: International Validation Study of the Melanoma Institute Australia Sentinel Node Metastasis Risk Nomogram
Location:Veterans Memorial Auditorium
Caroline Gjorup
Glasgow, Amy
Mayo Clinic
P31: Accuracy of DOTATATE PET/CT in the Preoperative Planning of Small Bowel Neuroendocrine Tumor Resection
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Amy Glasgow
Glass, Charity
Dana-Farber Cancer Institute/ Brigham & Women's Hospital/ Massachusetts General Hospital
2: Racial disparities in locoregional recurrence in patients with stage I-III, hormone receptor positive breast cancer enrolled in the NSABP B-42 trial
Location:Veterans Memorial Auditorium
Charity Glass
9: Breast cancer-related lymphedema and its relationship to major landmark trials in surgical oncology and radiation oncology
Location:Veterans Memorial Auditorium
Charity Glass
Glazer, Evan
University of Tennessee Health Science Center
The Role of Minimal Residual Disease Detection in the Management of GI Cancers
Location:Ballroom A
Evan Glazer
Gleisner, Ana
Department of Surgery, University of Colorado Anschutz Medical Campus
P19: Pathological Features Associated With Lymph Node Disease in Patients with Appendiceal Neuroendocrine Tumors.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Ana Gleisner
Gnant, Michael
Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
12: Impact of imaging-guided localization on performance of tailored axillary surgery in patients with clinically node-positive breast cancer: Prospective study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Michael Gnant
17: Axillary dissection to determine nodal burden to inform systemic therapy recommendations for clinically node-positive breast cancer: Pre-planned substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Michael Gnant
Godley, Frederick
Department of Surgery, Section of General Surgery and Surgical Oncology, University of Chicago Medical Center. Chicago
P53: Therapeutic Implications of Germline Testing in Peritoneal Mesothelioma
Location:SSO HUB: Rare/Metastatic Cancers Zone
Frederick Godley
Goedegebuure, Peter
Washington University in St. Louis, Department of Surgery, St. Louis, MO
22: The Long non-coding RNA RAMS11 Promotes Chemotherapy Resistance in-vivo in Metastatic Colorectal Cancer.
Location:Ballroom C
Peter Goedegebuure
Goel, Neha
University of Miami
Integrating Genetic Ancestry into Clinical Cancer Research
Location:Ballroom C
Neha Goel
Questions and Discussion
Location:Ballroom C
Neha Goel
Sarcoma Poster Presentations 1
Location:SSO HUB: Melanoma & Sarcoma Zone
Neha Goel
Goff, Stephanie
NIH/NCI/CCR/Surgery Branch
Novel Approaches to Modification of TIL for Therapeutic Treatment
Location:SSO HUB Theater
Stephanie Goff
Golas, Benjamin
Mount Sinai Health System
P80: Accuracy of Clinical Staging for Intramural (T2) Gastric Cancer: Survival Outcomes Following Upfront Surgical Resection Compared to Risk of Overtreatment with Neoadjuvant Therapy
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Benjamin Golas
Golshan, Mehra
Yale School of Medicine
CON: Stage IV Breast Cancer is Not an Operative Problem
Location:Veterans Memorial Auditorium
Mehra Golshan
Rebuttal and Q & A
Location:Veterans Memorial Auditorium
Mehra Golshan
Gonda, Amber
University of California, Irvine
P49: Convolutional Neural Network to Predict Peritoneal Carcinomatosis Risk in Gastric Cancer
Location:SSO HUB: Rare/Metastatic Cancers Zone
Amber Gonda
P50: Novel Vascularized Microtumor (VMT) Model of Peritoneal Carcinomatosis (PC) with Mesothelial-Lined Chambers and Submesothelial Stroma that Mimic the Peritoneal Cavity
Location:SSO HUB: Rare/Metastatic Cancers Zone
Amber Gonda
Gonen, Mithat
Department of Biostatistics, Memorial Sloan Kettering Cancer Center
27: The Prognostic Value of Pre- and Post-Neoadjuvant Chemotherapy Serum Carcinoembryonic Antigen Levels in Patients Having Resection of Colorectal Liver Metastases
Location:Ballroom C
Mithat Gonen
37: Hepatic Artery Infusion Chemotherapy Compared to Y90 for Treatment of Unresectable Colorectal Liver Metastases: A Multi-Institutional Comparative Study
Location:Ballroom B
Mithat Gonen
P20: Microsatellite Instability (MSI): The Transition from Favorable to Unfavorable Outcomes with Lymph Node Metastases
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Mithat Gonen
Goryunova, Marina
The Ohio State University
P57: Phosphorylation of IWS1 by AKT Maintains Liposarcoma Tumor Heterogeneity through Preservation of Cancer Stem Cell Phenotypes and Mesenchymal-Epithelial Plasticity
Location:SSO HUB: Melanoma & Sarcoma Zone
Marina Goryunova
Gosher, Noa
Tel Aviv Sourasky Medical Center
P81: Neoadjuvant Chemotherapy for Gastric Cancer in the Elderly: Are We Accomplishing Our Treatment Goals or Should we Consider an Upfront Surgery Approach
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Noa Gosher
Gottesman, Michael
National Cancer Institute, Laboratory of Cell Biology
P30: Validating a Genome-wide CRISPR Screen Determining Mechanisms of Drug Resistance in Pancreatic Adenocarcinoma
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Michael Gottesman
Gould, Jon
Medical College of Wisconsin, Department of General Surgery
87: Identifying Optimal Surgical Timing Relative to SARS-CoV-2 Infection Using COVID-19 Severity in Cancer Patients
Location:Ballroom B
Jon Gould
Grabbe, Stephan
University of Mainz Medical Center
63: Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)
Location:Veterans Memorial Auditorium
Stephan Grabbe
Graf Finckenstein, Friedrich
Iovance Biotherapeutics, Inc., San Carlos, CA, USA
64: Lifileucel TIL Cell Therapy in Patients With Advanced Melanoma After Progression on Immune Checkpoint Inhibitors (ICI) and Targeted Therapy: Tumor Tissue Procurement Data from the C-144-01 Study
Location:Veterans Memorial Auditorium
Friedrich Graf Finckenstein
Graff, Stephanie
Lifespan Cancer Institute
P7: Genomic characterization of breast cancer metastases reveals differences in rates of PIK3CA mutation across metastatic sites and worse survival in patients with concurrent CDH1 mutation treated with PI3K inhibitor
Location:SSO HUB: Breast & Endocrine Zone
Stephanie Graff
Graham, Paul
UT MD Anderson Cancer Center
Questions and Discussion
Location:Ballroom C
Paul Graham
Why and When can Adrenal Metastasectomy be Appropriate from a Surgeon Perspective?
Location:Ballroom C
Paul Graham
Grandhi, Miral
Rutgers Cancer Institute of New Jersey
HPB Parallel Session 1
Location:Ballroom B
Miral Grandhi
Greco, Stephanie
Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, USA
77: Current Patterns of Care and Outcomes for Dermatofibrosarcoma Protuberans: An International Multi-institutional Collaborative
Location:Ballroom A
Stephanie Greco
Greenberg, Anya
University of California, San Francisco, School of Medicine
P56: A Data Driven Approach for Individualized Risk Prediction of Serious Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Location:SSO HUB: Rare/Metastatic Cancers Zone
Anya Greenberg
Greenberg, Ariel
Tel Aviv Sourasky Medical Center
P81: Neoadjuvant Chemotherapy for Gastric Cancer in the Elderly: Are We Accomplishing Our Treatment Goals or Should we Consider an Upfront Surgery Approach
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Ariel Greenberg
Greer, Jonathan
Johns Hopkins University School of Medicine
28: Tumor Deposits Are Associated with a Higher Risk of Peritoneal Disease in Non-Metastatic Colorectal Cancer Patients
Location:Ballroom C
Jonathan Greer
71: Intra-and interpatient drug response heterogeneity exist in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastrointestinal cancers
Location:Ballroom B
Jonathan Greer
Gregory, Stephanie
National Institutes of Health, National Cancer Institute
P51: Hyperthermic intraperitoneal chemotherapy restores physiologic tumor stiffness & stimulates lymphocyte proliferation & recruitment
Location:SSO HUB: Rare/Metastatic Cancers Zone
Stephanie Gregory
Griffin, James
Piedmont Healthcare
Which Practice Setting is Best for Me? Exploring all the Options
Location:SSO HUB Theater
James Griffin
Griffin, Michelle
Stanford University
39: Mechanoresponsive Pancreatic Ductal Adenocarcinoma Cancer Associated Fibroblasts Shows an FAK-Dependent Subtype Divergent from Canonical Fibrotic TGFB-Pathway Dependence
Location:Ballroom B
Michelle Griffin
Griffith, Brian
University of Michigan
41: Defining the immune microenvironment surrounding pancreatic cancer using single cell RNA sequencing
Location:Ballroom B
Brian Griffith
Grignol, Valerie
The Ohio State University
82: Socioeconomic Disparities in the Treatment and Survival of Extremity Soft Tissue Sarcoma
Location:Ballroom B
Valerie Grignol
P59: Comparing complete compartmental resection with tumor only resection of retroperitoneal soft tissue sarcoma using the win ratio
Location:SSO HUB: Melanoma & Sarcoma Zone
Valerie Grignol
Surgical Cytoreduction for Metastatic GIST: Who, When, and Why?
Location:SSO HUB: Melanoma & Sarcoma Zone
Valerie Grignol
Grimm, Lars
Duke University Hospital
P10: High Risk Screening in Women with BRCA1/2 Mutations Age 70 and Above
Location:SSO HUB: Breast & Endocrine Zone
Lars Grimm
P6: Short-term outcomes in DCIS patients managed without initial surgery
Location:SSO HUB: Breast & Endocrine Zone
Lars Grimm
Grob, Jean-Jacques
Hôpital de la Timone
63: Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)
Location:Veterans Memorial Auditorium
Jean-Jacques Grob
Gronchi, Alessandro
Fondazione IRCCS Istituto Nazionale dei Tumori
Case Presentation and Discussion
Location:Ballroom A
Alessandro Gronchi
P58: Immune infiltrate of primary retroperitoneal sarcomas (RPS): a prognostic study
Location:SSO HUB: Melanoma & Sarcoma Zone
Alessandro Gronchi
P64: Surgical management of the duodenum during multivisceral resection for retroperitoneal sarcoma (RPS)
Location:SSO HUB: Melanoma & Sarcoma Zone
Alessandro Gronchi
Review of the Current Literature
Location:Ballroom A
Alessandro Gronchi
Grossi, Sara
University of California, San Diego
18: Clinical Impact of Semi-Annual Mammography in Patients Undergoing Breast Conserving Surgery Following Neoadjuvant Therapy
Location:Veterans Memorial Auditorium
Sara Grossi
Grotz, Travis
Mayo Clinic
70: Oncologic outcomes of cytoreductive surgery and HIPEC for highly selected patients with pancreatic ductal adenocarcinoma
Location:Ballroom B
Travis Grotz
Intraperitoneal IL-2
Location:SSO HUB: Rare/Metastatic Cancers Zone
Travis Grotz
Management of Extensive PMP
Location:Ballroom C
Travis Grotz
Novel Intraperitoneal Therapies
Location:SSO HUB: Rare/Metastatic Cancers Zone
Travis Grotz
P31: Accuracy of DOTATATE PET/CT in the Preoperative Planning of Small Bowel Neuroendocrine Tumor Resection
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Travis Grotz
P61: Outcomes After Resection of Locally Recurrent Retroperitoneal Sarcoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Travis Grotz
P63: Is there a benefit to radiation and surgery in specific histologic subtypes of retroperitoneal sarcoma?
Location:SSO HUB: Melanoma & Sarcoma Zone
Travis Grotz
P84: Outcomes After Minimally Invasive Gastrectomy for Locally Advanced Gastric Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Travis Grotz
Grubbs, Elizabeth Gardner
The University of Texas MD Anderson Cancer Center
P74: Perceptions of Readiness for Practice after Complex General Surgical Oncology Fellowship: A Survey Study
Location:SSO HUB: Rare/Metastatic Cancers Zone
Elizabeth Gardner Grubbs
Gruber, Günther
Institute of Radiotherapy, Clinic Hirslanden, Zurich, Switzerland
12: Impact of imaging-guided localization on performance of tailored axillary surgery in patients with clinically node-positive breast cancer: Prospective study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Günther Gruber
17: Axillary dissection to determine nodal burden to inform systemic therapy recommendations for clinically node-positive breast cancer: Pre-planned substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Günther Gruber
Grunkemeier, Gary
Providence Oregon Regional Shared Services
P47: Predicting recurrence after a negative sentinel lymph node in melanoma: the model changes with time and sites of recurrence
Location:SSO HUB: Melanoma & Sarcoma Zone
Gary Grunkemeier
Guardino, Nicholas
Stanford University
39: Mechanoresponsive Pancreatic Ductal Adenocarcinoma Cancer Associated Fibroblasts Shows an FAK-Dependent Subtype Divergent from Canonical Fibrotic TGFB-Pathway Dependence
Location:Ballroom B
Nicholas Guardino
Gudmundsdottir, Hallbera
Department of Surgery, Mayo Clinic
70: Oncologic outcomes of cytoreductive surgery and HIPEC for highly selected patients with pancreatic ductal adenocarcinoma
Location:Ballroom B
Hallbera Gudmundsdottir
P31: Accuracy of DOTATATE PET/CT in the Preoperative Planning of Small Bowel Neuroendocrine Tumor Resection
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Hallbera Gudmundsdottir
Guglielmi, Alfredo
Department of Surgery, Dentistry, Gynecology, and Pediatrics, Division of General and Hepato-Biliary Surgery, University of Verona, University Hospital G.B. Rossi, Verona, Italy
34: An Artificial Intelligence Approach to Determining Optimal Margin Width in Patients Undergoing Hepatectomy for Intrahepatic Cholangiocarcinoma
Location:Veterans Memorial Auditorium
Alfredo Guglielmi
Guo, Jason
Stanford University
39: Mechanoresponsive Pancreatic Ductal Adenocarcinoma Cancer Associated Fibroblasts Shows an FAK-Dependent Subtype Divergent from Canonical Fibrotic TGFB-Pathway Dependence
Location:Ballroom B
Jason Guo
Guragain, Diwakar
UC San Diego
76: Single nuclei RNAseq Reveals Dedifferentiation States from Human ICCs to GIST
Location:Ballroom A
Diwakar Guragain
Gushchin, Vadim
Mercy Medical Center
24: Sufficient Regional Lymph Node Examination for Staging High-Grade Appendix Cancer
Location:Ballroom C
Vadim Gushchin
Back to Top
